Tirzepatide, marketed as Mounjaro, is a medication prescribed for the treatment of type 2 diabetes. A frequently reported side effect associated with its use is fatigue. This sensation of weariness or reduced energy can manifest in various ways, impacting an individual’s daily activities and overall well-being.
Understanding the mechanisms that contribute to this fatigue is important for patients and healthcare providers. It allows for better management of the side effect and informed decisions regarding continued treatment. Addressing fatigue can significantly improve a patient’s quality of life while managing their diabetes. Furthermore, awareness of this potential side effect can promote realistic expectations and proactive communication with healthcare professionals.